Source: Financial Modeling Prep · peers by sector/industry
Insider activity (SEC Form 4)
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
Valuation
Trading at 29.6× sales vs its 31.8× historical median P/S.
Fair value ≈ $0.18 · price $0.17 today
Undervalued · 7% below
Loading valuation…
Fair-value line = the stock's median historical P/S × sales per share. Price below the orange line = cheap vs its own history; above = expensive. Not investment advice.
$IGXT I am surprised we have not seen a class action lawsuit for this stock. $ATAI who invested in IGXT took anything of value and discarded the rest leaving common stock investors with nothing.
$IGXT "holders of the Company’s shares will not receive any payments for, or distributions on, their shares in connection with the CCAA proceedings. It is also expected that the Company, Residual IGX and New ParentCo, entities that will hold the remaining assets and liabilities that atai chose not to purchase as part of the Transaction, will file for bankruptcy in the coming weeks under the laws of their respective jurisdictions."
$IGXT It's complete. "atai acquired all of the issued and outstanding shares of IGX" and will "exchange of the shares of IGX, on a one-for-one basis, for common shares of New ParentCo."
$IGXT IMPORTANT: we need assistance from someone in or near Montreal.
Per the most recent post by Intelgenx, the merger must be approved by the Québec Superior Court (Commercial Division). We called up this division to get details. They cannot provide the information on the phone. However, you can visit the courthouse in person and you can read the file.
Where: Montreal Courthouse
Address: 1 Notre-Dame St. East, Montreal, QC H2Y 1B6, Canada
go to counter 1.140
ask to see file #50011064115245
You ARE allowed to copy and/or take pictures of the file. PLEASE so do and post your findings here.
Everyone will thank you.
$IGXT "The parties currently expect to obtain final approval from the Québec Superior Court (Commercial Division) and close the transaction prior to September 30, 2024."
$IGXT to reiterate, "IntelGenx and atai Life Sciences AG (“atai”) have now initiated the process to complete the purchase and sale transaction." So we will be subject to a conversion rate or ratio for stock, what will it be
